Cited by — Predicting Chemoresistance in HER2-low Breast Cancer: Histologic Grade, MRI Non-mass Enhancement, and Clinical T Stage | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Predicting Chemoresistance in HER2-low Breast Cancer: Histologic Grade, MRI Non-mass Enhancement, and Clinical T Stage.
No admitted local citation edges point to this work yet.
